We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01487304
First Posted: December 7, 2011
Last Update Posted: October 17, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Novo Nordisk A/S
December 5, 2011
December 7, 2011
October 17, 2016
April 2005
June 2006   (Final data collection date for primary outcome measure)
Breast tenderness
Same as current
Complete list of historical versions of study NCT01487304 on ClinicalTrials.gov Archive Site
Patient treatment satisfaction after switch to low dose HRT
Same as current
Not Provided
Not Provided
 
Impact of Professional Societies' Recommendations on Practical Use of Hormone Replacement Therapy
Impact of Professional Societies Recommendations on Practical Use of Hormone Replacement Therapy - Project "WOMAN 2005"
This study is conducted in Europe. The aim of this study is to verify the therapeutic effects of low-dose hormone replacement therapy (HRT) in female patients over adequately long time period in normal clinical practice conditions in the Czech Republic.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Post-menopausal women suffering from climacteric symptoms who could benefit a switch from standard therapy to low dose therapy at the discretion of the individual physician
  • Menopause
  • Hormone Replacement Therapy, Post-Menopausal
Drug: Marketed low dose hormone replacement therapy
A low dose of marketed HRT products prescribed at the discretion of the treating physician
Low dose HRT
Intervention: Drug: Marketed low dose hormone replacement therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
3760
June 2006
June 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Post-menopausal
Sexes Eligible for Study: Female
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Czech Republic
 
 
NCT01487304
KLIM-1937
No
Not Provided
Not Provided
Novo Nordisk A/S
Novo Nordisk A/S
Not Provided
Study Director: Global Clinical Registry (GCR, 1452) Novo Nordisk A/S
Novo Nordisk A/S
October 2016